Janice Eng and Shoukat Dedhar win 2015 Distinguished Medical Lecturer Awards
January 5, 2016
Shoukat Dedhar, a Professor in the Department of Biochemistry and Molecular Biology, and Janice Eng, a Professor in the Department of Physical Therapy, are recipients of the 2015 Faculty of Medicine Distinguished Medical Research Lecturer (DMRL) Awards.
Dr. Dedhar, the recipient in the Basic Sciences category, focuses on cancer biology and cell adhesion mechanisms, particularly on in vivo approaches to cancer treatment. He is most known for his discovery of a protein that targets cancer, cardiovascular disease and inflammation. He also discovered a major factor contributing to cancer cell survival and metastases. He was recently granted over $4 million for his research through a CIHR Foundation Grant.
Dr. Dedhar’s lecture, “The Tumor Microenvironment and Cancer Metastasis,” will cover the development of a new targeted cancer therapy.
BC Cancer Agency, Canada
Professor, Department of Biochemistry and Molecular Biology, University of British Columbia, and Distinguished Scientist, Department of Integrative Oncology, BC Cancer Agency, Vancouver, Canada. Dr Dedhar received his BSc(Hons) in Biochemistry from the University in Aberdeen, Scotland, and his PhD from the University of British Columbia (UBC), Vancouver, Canada in 1984. He carried out a Postdoctoral Fellowship in the laboratory of Dr. Erkki Ruoslahti at the Burnham Institute, in La Jolla, California, USA. Dr Dedhar is a Distinguished Scientist at the BC Cancer Agency and Full Professor in the Department of Biochemistry and Molecular Biology at University of British Columbia ( UBC). He is noted for his discovery of Integrin-Linked Kinase (ILK) and his research is currently focused on the role of ILK signaling in cancer progression, the molecular basis and targeting of centrosome clustering in cancer cells, and therapeutic targeting of tumor hypoxia effectors, Carbonic Anhydrases IX and XII. Dr Dedhar has received several awards, including the Distinguished Scholar award from the Michael Smith Foundation for Health Research (MSFHR) , the Terry Fox Cancer Research Scientist award of the National Cancer Institute of Canada ( NCIC), Distinguished medical research lectureship award of UBC, and the Robert L Noble Prize (2013), for “Outstanding achievement in Cancer Research”. Dr Dedhar is co-founder of SignalChem Lifesciences Corp (SLC), a Biotechnology company developing novel therapeutics targeting Protein kinases, Tumor Hypoxia and Metabolism. Dr. Dedhar is an author of over 200 peer- reviewed papers and review articles, and an inventor on 24 patents.
Previously on Ismailimail…